Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06625749 · ClinicalTrials.gov registry record · NA
Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery
A NA study of Refractive Surgery and Refractive Error - Myopia, sponsored by OnPoint Vision.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06625749: Recruiting NA study of Refractive Surgery and Refractive Error - Myopia, sponsored by OnPoint Vision.
NCT06625749 is a NA study of Refractive Surgery and Refractive Error - Myopia that is actively recruiting participants, run by OnPoint Vision. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06625749, a NA study of Refractive Surgery and Refractive Error - Myopia, is actively recruiting participants, sponsored by OnPoint Vision.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study to evaluate the safety and effectiveness of the AccuraSee™ intraocular pseudophakic capsular lens (IOPCL) to improve near and/or intermediate vision following previous cataract surgery.
Primary Outcome
Improvement in uncorrected near visual acuity (UCNVA) (at 40 cm/16 inches) at 12 months postoperatively. At least 75% of treated eyes should achieve an uncorrected near visual acuity (UCNVA) of 20/32 or better.
Conditions Studied
Interventions
- DEVICE Accurasee™ IOPCL
Study Locations (1)
Ohio
- Midwest Vision Partners - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-09-23 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT06625749 shows while recruiting
NCT06625749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Refractive Surgery appearing as the primary indexed condition, and to 1 intervention - of which Accurasee™ IOPCL is the first listed.
NCT06625749 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06625749 about?
NCT06625749 is a clinical study titled "Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery". This is a study to evaluate the safety and effectiveness of the AccuraSee™ intraocular pseudophakic capsular lens (IOPCL) to improve near and/or intermediate vision following previous cataract surgery.
What is the current status of trial NCT06625749?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-09-23. Estimated completion is 2026-03.
What conditions does trial NCT06625749 study?
This clinical trial studies the following conditions: Refractive Surgery, Refractive Error - Myopia.
What interventions are being tested in trial NCT06625749?
The interventions under investigation include: Accurasee™ IOPCL (DEVICE).
Who is sponsoring clinical trial NCT06625749?
This trial is sponsored by OnPoint Vision, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06625749 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06625749's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI